Table 3.

Comparison of the Change in Regional Cerebral Blood Perfusion (SPECT CT Brain) (From Baseline to the End of 24 Weeks) Between the Treatment Groups

Variables	Groups		P Value
	Group-1 (M-ECT) (n = 30)	Group-2 (Clozapine) (n = 30)
	Mean ± SEM	Mean ± SEM
RLPFC	−0.014 ± 0.004	0.002 ± 0.006	.035
LLPFC	−0.025 ± 0.008	0.017 ± 0.009	.001
RMPFC	−0.009 ± 0.005	0.016 ± 0.006	.001
LMPFC	−0.019 ± 0.007	0.007 ± 0.006	.007
RLT	−0.019 ± 0.006	0.005 ± 0.007	.023
LLT	−0.011 ± 0.004	0.017 ± 0.005	<.001
RMT	−0.035 ± 0.008	−0.024 ± 0.010	.375
LMT	−0.022 ± 0.013	0.021 ± 0.015	.047
RSP	−0.013 ± 0.008	0.005 ± 0.010	.166
LSP	−0.014 ± 0.010	−0.007 ± 0.008	.547
RIP	−0.001 ± 0.008	−0.004 ± 0.009	.773
LIP	0.015 ± 0.009	0.006 ± 0.007	.459

Data are in mean ± SEM. Values reflect the difference of regional cerebral blood perfusion of patient from normal reference, and more negative value suggests better cerebral blood flow.

RLPFC, right lateral prefrontal cortex; LLPFC, left lateral prefrontal cortex; RMPFC, right medial prefrontal cortex; LMPFC, left media prefrontal cortex; RLT, right lateral temporal; LLT, left lateral temporal; RMT, right medial temporal; LMT, left medial temporal; RSP, right superior parietal; LSP, left superior parietal; RIP, right inferior parietal; LIP, left inferior parietal.